| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |